Dizal to Showcase Drug Advances in Hematologic and Lung Cancers at ASCO 2025 Dizal Pharmaceutical plans to present outstanding results of its innovative therapies for hematological malignancies and lung cancer at ASCO 2025.

Dizal to Showcase Drug Advances in Hematologic and Lung Cancers at ASCO 2025 #China #Shanghai #DZD8586 #Dizal #DZD6008

Dizal to Present Innovative Data on Cancer Treatments at ASCO 2025 Dizal will reveal groundbreaking studies in hematologic cancers and lung cancer treatment at the ASCO 2025 conference, focusing on their innovative drugs DZD8586 and DZD6008.

Dizal to Present Innovative Data on Cancer Treatments at ASCO 2025 #China #Shanghai #DZD8586 #Dizal #DZD6008